ANCA ASSOCIATED VASCULITIS (AAV)

Clinical trials for ANCA ASSOCIATED VASCULITIS (AAV) explained in plain language.

Never miss a new study

Get alerted when new ANCA ASSOCIATED VASCULITIS (AAV) trials appear

Sign up with your email to follow new studies for ANCA ASSOCIATED VASCULITIS (AAV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 10 Not yet recruiting 3 Not yet finished but already full! 1 Terminated 1

CAR t therapy takes on lupus and other autoimmune diseases

Disease control Terminated

This early-phase trial tested a single dose of IMPT-514, a personalized CAR T cell therapy, in 3 adults with active, treatment-resistant lupus, vasculitis, or inflammatory myopathy. The main goal was to check safety and side effects. The study was terminated early, so results are…

Matched conditions: ANCA ASSOCIATED VASCULITIS (AAV)

Phase: EARLY_PHASE1 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control

Last updated May 08, 2026 12:03 UTC

ANCA ASSOCIATED VASCULITIS (AAV)

Get alerted when new ANCA ASSOCIATED VASCULITIS (AAV) trials appear

CAR t therapy takes on lupus and other autoimmune diseases